Biocrossroads News Archives - Page 2 of 6 - The Central Indiana Corporate Partnership

BioCrossroads releases 2022 Indiana Life Sciences Capital Report showing $6.8B in capital investment in the life sciences sector 

Raquel Bahamonde2023-04-17T08:34:34-04:00April 17, 2023|

INDIANAPOLIS (April 17, 2023) — BioCrossroads today released its annual analysis of capital invested to grow and support Indiana life sciences companies in 2022. “We are pleased to report that Indiana experienced capital investment of more than $6.8 billion in 2022 that will directly result in the creation of 3,000 new life sciences sector jobs in the state,” said Jane Dunigan-Smith, BioCrossroads’ senior vice president, chief strategy officer and managing director of Seed Funds. “This includes more than $600 million in venture capital to support innovation and start-ups along with $2.8 billion in other capital investments for establishing, expanding or upgrading Indiana life sciences facilities.” Indiana’s life sciences sector contributed $77 billion to the state’s economy last year. Total market cap value grew by 20 percent over 2021, from $455.7 billion to $548.7 billion, driven largely by Eli Lilly and [...]

BioCrossroads names new members to leadership team

Raquel Bahamonde2023-03-21T15:25:53-04:00March 21, 2023|

INDIANAPOLIS (March 21, 2023) — BioCrossroads announced today that Jane Dunigan-Smith and Mike Bolinder have joined the organization’s leadership team. Dunigan-Smith, senior vice president, chief strategy officer and managing director of Seed Funds, comes to BioCrossroads after 19 years with Eli Lilly and Company where she spent a significant portion of her career in commercialization, corporate strategy and operations. She also has a strong background in accounting and finance, having spent the early part of her career as a Certified Public Accountant, and serves on the boards of Diagnotes, Inc. and Allinaire Therapeutics. “Jane’s multi-faceted experience positions her to manage the Seed Funds and lead our strategy at a time when Indiana’s life sciences sector is expanding and innovating in multiple areas,” said Patty Martin, president and CEO, BioCrossroads. “One example is our work to establish Indiana as a global [...]

White Paper: Recruiting and retaining talent who make life-saving medicine; State of Pharmaceutical Manufacturing Workforce in Indiana

Raquel Bahamonde2023-03-09T09:52:35-05:00March 9, 2023|

Indiana is experiencing significant statewide growth in pharmaceutical manufacturing (Indiana ranks #1 in the nation for pharmaceutical exports) but this boom in high-quality, high-paying jobs is challenged by a shortage of qualified workers. BioCrossroads, in partnership with Ascend Indiana, convened pharmaceutical manufacturers, postsecondary education institutions, and state officials to explore how to develop a robust talent pipeline to support continued growth. The two initiatives have released the following white paper: Recruiting and retaining talent who make life-saving medicine: State of the Pharmaceutical Manufacturing Workforce in Indiana [READ WHITE PAPER]

Indiana leads the U.S. in pharmaceutical exports

Raquel Bahamonde2023-03-02T14:39:58-05:00March 2, 2023|

INDIANAPOLIS (March 2, 2023) -- Indiana leads the United States in pharmaceutical exports, according to new data from the Indiana Business Research Center at the Indiana University Kelley School of Business. Life sciences exports have always been a strong area for the state. Indiana has been one of the top three states in exports for all life sciences products – pharmaceuticals, medical device, and agbiosciences -- for more than a decade. In 2022, $13 billion of these products were shipped all over the world. In addition, 2022 saw a record amount of venture capital raised by Indiana start-ups for the third straight year – increasing to $620 million, an increase of nearly $200 million from 2021. Other key indicators and statistics for 2022 include: The economic output of the state’s life sciences industry was $77 billion, driven by more than [...]

BioCrossroads releases 2022 Annual Report

Raquel Bahamonde2023-03-09T09:09:22-05:00March 2, 2023|

2022 was a year for celebration for BioCrossroads, not only because the life sciences sector continued strong growth and success, but because it was the organization’s 20th anniversary which marked a time to not only reflect on past accomplishments and achievements, but to also look forward to the future of the industry and the next generation of talent. MASSIVE MARKET KNOWLEDGE BioCrossroads undertook an ambitious year of coordinating and releasing capital and economic impact reports; profiles of innovators and change makers; and tracking the organization’s two decades of work – publishing ten reports in all. TOUTING TALENT To honor the next generation of life sciences leaders, BioCrossroads developed the 23 PAIR (Promising Achievers in Innovation and Research) recognition program in 2022. ENGAGING THROUGH EVENTS With more than 100 events developed and hosted over the last two decades, BioCrossroads took advantage [...]

BioCrossroads President and CEO Patty Martin to step down

Raquel Bahamonde2023-02-14T10:01:05-05:00February 14, 2023|

INDIANAPOLIS (Feb. 14, 2023) —BioCrossroads announced today that Patty Martin, president and CEO, has decided to step down from the organization. Martin, who is an ardent and passionate catalyst and connector for the life sciences in Indiana, will continue her engagement with the life sciences industry in the private sector. “Patty’s energy and passion have been felt throughout Indiana’s life sciences sector over the last four years,” said BioCrossroads Board Chair Dan Peterson and vice president of Government and Industry Affairs, Cook Group. “Her guidance and leadership have been especially critical as BioCrossroads reached a significant milestone with their 20th anniversary in 2022. As we look toward the future of the organization, the foundation she laid will continue to support new and exciting opportunities for the sector.” Martin advanced the important work of BioCrossroads through its collaborative, investment, and programming [...]

Indiana’s life sciences industry continues to rank among the top 10 in national report

Raquel Bahamonde2022-11-14T10:08:42-05:00November 14, 2022|

INDIANAPOLIS (Nov. 14, 2022) – The State of Indiana, as well as seven Hoosier cities, have once again been recognized for their national life science strengths, according to Biotechnology Industry Organization (BIO) and TEConomy Partners’ biennial survey of the U.S. life sciences industry. The report, The U.S. Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward, measures growth in the biosciences sector* from 2018 to 2021 for the entire country and each of the fifty states. Indiana continued its top 10 employment ranking in the life sciences, with a sizeable workforce and industry concentration in the areas of agriculture feedstock and chemicals, drugs and pharmaceuticals, and medical devices and equipment. The state is also one of only eight states with employment specializations in three of five bioscience sectors. In addition, Indiana is ranked third for academic biosciences research and development [...]

New report tracks 20 years of BioCrossroads and life sciences industry’s success

Raquel Bahamonde2022-10-06T13:41:14-04:00October 6, 2022|

INDIANAPOLIS (Oct. 6, 2022) – Today, BioCrossroads released a new report from TEConomy that follows the impact of BioCrossroads and Indiana’s life sciences sector over the last two decades -- BioCrossroads and the Indiana Life Sciences Ecosystem: Tracking Two Decades of Progress and Charting a Path for Sustained Success. The study highlights statistics that include the life sciences sector’s outperformance of Indiana’s economy since 2001 and outsized portion of total new jobs in the state over the past two decades. The report points out that “over the course of the next decade, it is expected that the life sciences will remain a key strategic driver of economic development in Indiana.” Although the life sciences represented just over 2% of the state’s total jobs in 2020, they contributed 23.7% net new jobs from 2001 to 2020. Of the nearly 50,000 new [...]

Nora Doherty recognized as 2022 Watanabe Life Sciences Champion for strategic and meaningful impact on Indiana’s life sciences industry

Raquel Bahamonde2022-09-26T10:06:27-04:00September 22, 2022|

In addition to receiving the August M. Watanabe award, Doherty also received the Sagamore of the Wabash, the state's highest honor, from Indiana Gov. Eric J. Holcomb. INDIANAPOLIS (Sept. 22, 2022) — BioCrossroads’ Board of Directors today named former executive vice president of strategy of BioCrossroads and managing director of the Indiana Seed Funds, Nora Doherty, as the recipient of the 2022 August M. Watanabe Life Sciences Champion of the Year Award. The prestigious honor, named in tribute to BioCrossroads’ late Chairman August Watanabe, was given to Doherty at today’s Indiana Life Sciences Summit and 20th Anniversary CELLebration. Some of Doherty’s most significant achievements included developing a market for Indiana’s life sciences start-ups, including forming and managing funding mechanisms, engaging with universities and start-ups, and organizing new enterprises. Recognizing the need for early stage or seed stage capital, BioCrossroads, [...]

BioCrossroads announces 23 PAIR (Promising Achievers in Innovation and Research) winners

Raquel Bahamonde2022-08-24T07:44:36-04:00August 24, 2022|

INDIANAPOLIS (August 24, 2022) -- BioCrossroads today announced the winners of its inaugural 23 PAIR (Promising Achievers in Innovation and Research), a new recognition program that celebrates and promotes the state’s next generation of life sciences leaders. Award winners have exhibited significant industry or academic impact and success and are in the early stages of their careers. “People are such a critical component of Indiana’s life sciences industry, and we’re thrilled to recognize some incredibly talented Hoosiers for their work,” said Lori LeRoy, executive vice president of communications for BioCrossroads. “Our inaugural group of winners is already making their marks in the life sciences industry whether it’s directing clinical trials, performing groundbreaking research, communicating information, developing IT protocols, or analyzing data.” 2022 23 PAIR WINNERS: Carly Streicher Labcorp Drug Development Casey Lillibridge Inotiv Daniel Sheik Amplified Sciences Duchess Adjei Beckman [...]

MAIN MENU

IMPORTANT LINKS

INITIATIVES